SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose.
Although excessive fructose intake is epidemiologically linked with dyslipidemia, obesity, and diabetes, the mechanisms regulating plasma fructose are not well known. Cells transfected with sodium/glucose cotransporter 5 (SGLT5), which is expressed exclusively in the kidney, transport fructose in vi...
Main Authors: | Taku Fukuzawa, Masanori Fukazawa, Otoya Ueda, Hideaki Shimada, Aki Kito, Mami Kakefuda, Yosuke Kawase, Naoko A Wada, Chisato Goto, Naoshi Fukushima, Kou-Ichi Jishage, Kiyofumi Honda, George L King, Yoshiki Kawabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3581502?pdf=render |
Similar Items
-
Agomelatine reduces circulating triacylglycerides and hepatic steatosis in fructose-treated rats
by: Vanessa Barbosa Veronesi, et al.
Published: (2021-09-01) -
Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis
by: Emma L. Shepherd, et al.
Published: (2021-04-01) -
Fructose and NAFLD: The Multifaceted Aspects of Fructose Metabolism
by: Prasanthi Jegatheesan, et al.
Published: (2017-03-01) -
Experimental model of hepatic steatosis by fructose in adult zebrafish: a pilot study
by: Jéssica Tonin Ferrari, et al.
Published: (2018-07-01) -
Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
by: Angela Woods, et al.
Published: (2017-03-01)